Skip to main content
All lobbying filings

EVONIK CORPORATION

EVONIK CORPORATION filed a Q3 report for EVONIK CORPORATION on October 20, 2025, reporting $60,000 in lobbying income.

Lobbying for EVONIK CORPORATION · Manufacturer of specialty chemicals

All filings by EVONIK CORPORATION · Everything EVONIK CORPORATION has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$60,000
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 7
Chemicals/Chemical Industry

Issues related to TSCA reform Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts

Environment/Superfund

Oversight of EPA rules and regulations S.623 / H.R.1415 - No IRIS Act Make American Healthy Again (MAHA) GRAS issue

Budget/Appropriations

FY26 appropriations actions H.R. 4 - Rescissions Act of 2025 - (PL 119-28) H.R. 1 - One Bill Beautiful Bill Act (OBBBA) reconciliation package (PL 119-21)

Taxation/Internal Revenue Code

General issues related to corporate tax S.615/H.R.640 - Chemical Tax Repeal Act H.R. 1 - One Bill Beautiful Bill Act (OBBBA) reconciliation package, Section 899 (PL 119-21)

Trade (domestic/foreign)

U.S./China ongoing trade issues Issues related to various trade agreement discussions USMCA Review Process

Railroads

Issues related to the Surface Transportation Board (STB) and rail mergers

Tariff (miscellaneous tariff bills)

Issues related to the Administrations tariff actions and related Congressional oversight

 Bills named in this filing 6

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem